PORTLAND, MAINE — ElleVet Sciences has developed a new veterinary CBD product to help reduce stress and discomfort in cats. The new Feline Paste product incorporates the company’s CBD+CBDA Complete Oil to provide everyday relief and neurological support for feline companions.
"After more than two years in development, we are ready to introduce ElleVet Feline Paste," said Amanda Howland, chief commercial officer at ElleVet Sciences. "A feline product that has been proven safe, highly-effective and palatable is a game-changer for feline care products."
The product is chicken flavored and can be administered at home through a “dial-a-dose” syringe.
"ElleVet Feline Paste is a great addition to the product line,” added Dr. Joe Wakshlag, chief veterinary medical officer at ElleVet Sciences and professor at Cornell University College of Veterinary Medicine. “Now pet owners have a new and much needed choice for their cats. Safety is key to any successful feline product. ElleVet has completed a long term safety study, which is the only CBD+CBDA product to have been proven safe for cats. Using a safe, full spectrum product in a palatable form is revolutionary in the feline world.”
The product will be available directly through ellevetsciences.com and sold through participating veterinary clinics, ElleVet stated.
According to ElleVet, the company was the first to conduct a clinical trial of its hemp CBD+CBDA formulation involving dogs with osteoarthritis. Cornell University helped facilitate the clinical trial, which was deemed successful.
Portland-based ElleVet Sciences was founded in 2017 to provide needed research and product development in the CBD pet space. The company has a vertically integrated supply chain, including its hemp source, manufacturing, direct sales and customer service.
Read more about new pet food and treat products.